Dexrazoxane
NDC 72266-235, Dexrazoxane for Injection, injection, powder, lyophilized, for solution, from Fosun Pharma USA Inc..
- Product NDC
- 72266-235
- Status
- Listed
- Labeler
- Fosun Pharma USA Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA207321
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72266-235 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEXRAZOXANE HYDROCHLORIDE250 mg/25mL
Pharmacologic classes
Cytoprotective Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72266-235-01 | 72266023501 | 1 VIAL in 1 CARTON (72266-235-01) / 25 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c1d98fbe-5fd9-4518-b1a5-fac92e32928fMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=72266-235
Use it
Look up 72266-235 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72266-235 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72266-235. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.